Effect of Vasodilator Therapy on Sympathetic Activity in Patients with Impaired Left Ventricular Function

[1]  R. Gorlin,et al.  Importance of left ventricular chamber size in determining the response to hydralazine in severe chronic heart failure. , 1980, The New England journal of medicine.

[2]  R. Gorlin,et al.  Dose requirements of hydralazine in patients with severe chronic congestive heart failure. , 1980, The American journal of cardiology.

[3]  J. Franciosa,et al.  Immediate Effects of Hydralazine-Isosorbide Dinitrate Combination on Exercise Capacity and Exercise Hemodynamics in Patients with Left Ventricular Failure , 1979, Circulation.

[4]  A. DeMaria,et al.  Hydralazine-induced tachycardia and sodium retention in heart failure. Hemodynamic and symptomatic correction by prazosin therapy. , 1978, Archives of internal medicine.

[5]  J. Cohn,et al.  Vasodilator Therapy of Cardiac Failure , 1977 .

[6]  M. da Prada,et al.  Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range. , 1976, Life sciences.

[7]  E. Uhlich,et al.  Radioimmunoassay of Arginine Vasopressin in Human Plasma* , 1975, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[8]  E. Haber,et al.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. , 1969, The Journal of clinical endocrinology and metabolism.

[9]  E. Braunwald,et al.  F. SYMPATHETIC ACTIVITY AND NEUROTRANSMITTER DEPLETION IN CONGESTIVE HEART FAILURE , 1966 .